RSS Feed This entry was posted on Thursday, March 11th, 2010 at 3:30 pm and is filed under FYI. You can leave a response, or trackback from your own site.
 |
- At Other Sites
- Beam Me Up
- Book Review
- Breaking News
- CBO
- Discussion
- From the Trenches
- FYI
- Ground Control to Sen. Democrats
- Health Alert
- 2008 Election
- African AIDS
- Babies
- Bad Studies
- Book Reviews
- Bush Health Plan
- Diabetics
- Drugs
- Health Care Access
- Health Care Costs
- Health Reform
- HSAs
- International
- Malpractice
- Media Advisory
- Medicaid
- Medical Economics
- Medical Tourism
- Mental Health
- Minimum Wage
- Portability
- Racial Disparities
- RAND Studies
- Safety
- Scary Forecasts
- SCHIP
- Seniors/Medicare
- Socialized Medicine
- Supply Side
- Telemedicine
- Transparency
- Uninsured
- Vet Care
- Vision Thing
- Workers Comp
- Hits & Misses
- Holiday
- In Memoriam
- In the News
- Interesting Videos
- Memorial Day
- New Videos
- NHS Update
- Notable and Quotable
- Obesity Update
- On Capitol Hill
- Personal Testimony
- Petition
- Plans
- Policy Update
- Question of the Week
- Quote of the Day
- Season's Greetings
- Song of the Season
- The People Speak Out
- Updates
Categories
Contributors
- Ron Bachman
- Michael Bond
- John Goodman
- Linda Gorman
- Robert Graboyes
- John R. Graham
- Devon Herrick
- Regina Herzlinger
- Roy Ramthun
- Greg Scandlen
Recent Posts
- If You Own a Gun, Should You Pay More for Health Care?
- QuickCare
- I’m Not Sure I Believe This
- Does Your Insurer “Steer” You to a Preferred List of Doctors?
- Will We See Ads Like this in the U.S.?
- Top 10 Public Health Disasters, the First Lady Books Ritzy Vacation During Recession, and Docs Leave Field Midcareer
- Seniors Know More than Polltakers
- Lessons from Massachusetts
- Unintended Consequences for Kids
- It’s Baaack! Return of the “Public Option”
Blogroll
Mar 11, 2010
In 2008, 28 percent of sales from the pharmaceutical industry’s top 100 products came from biologics; by 2014, that share is expected to rise to 50 percent.
Biologic drugs can be more expensive to manufacture; they are grown inside living cells rather than put together chemically, as conventional drugs are. But this does not fully account for their high prices. Another important factor is that they very rarely face competition from generic copies.
Congress is about to change that.
3 Responses to “Do You Know What Biologics Are?”
RSS
Twitter
YouTube
LinkedIn
Facebook
Flickr
Helium
March 11th, 2010 at 3:53 pm
Interesting issue. I suppose there should be some limit on patent protection.
March 11th, 2010 at 4:20 pm
I agree with Ken.
March 15th, 2010 at 11:54 am
Under current law, biologics technically loose patent protection. However, they also must undergo the same sort of testing required for name-brand biologics initial approval. In addition, biologic drugs are not substitutable by pharmacists so for all practical purposes, there is no such thing as a bio-generic. The industry prefers to call them biosimilar. It’s a complex issue with no easy answers.